Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Payables (2016 - 2025)

InspireMD (NSPR) has 16 years of Payables data on record, last reported at $1.8 million in Q3 2025.

  • For Q3 2025, Payables fell 70.59% year-over-year to $1.8 million; the TTM value through Sep 2025 reached $1.8 million, down 70.59%, while the annual FY2024 figure was $6.4 million, 584.13% up from the prior year.
  • Payables reached $1.8 million in Q3 2025 per NSPR's latest filing, up from $1.5 million in the prior quarter.
  • Across five years, Payables topped out at $6.4 million in Q4 2024 and bottomed at $404000.0 in Q3 2022.
  • Average Payables over 5 years is $2.2 million, with a median of $1.5 million recorded in 2025.
  • Peak YoY movement for Payables: plummeted 87.23% in 2022, then skyrocketed 912.38% in 2023.
  • A 5-year view of Payables shows it stood at $893000.0 in 2021, then dropped by 26.2% to $659000.0 in 2022, then soared by 42.49% to $939000.0 in 2023, then skyrocketed by 584.13% to $6.4 million in 2024, then plummeted by 72.71% to $1.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Payables were $1.8 million in Q3 2025, $1.5 million in Q2 2025, and $1.7 million in Q1 2025.